OTCMKTS:DOCMF Dr. Martens (DOCMF) Stock Price, News & Analysis → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free DOCMF Stock Alerts $1.08 +0.02 (+1.89%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.06▼$1.0950-Day Range$0.83▼$1.2152-Week Range$0.77▼$2.21Volume2,500 shsAverage Volume19,305 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Dr. Martens alerts: Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. About Dr. Martens Stock (OTCMKTS:DOCMF)Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCMF Stock News HeadlinesMay 17 at 12:32 AM | yahoo.comAvril Lavigne Dons Classic Dr. Marten Boots at 2024 Academy of Country Music AwardsMay 16 at 7:31 PM | msn.comDr Martens' 'comfy' sandals that 'go with every summer outfit' have price slashed by €44 in mega saleMay 14, 2024 | msn.comDr Martens 'no blisters' sandals that 'go with everything' have £35 off in saleMay 9, 2024 | americanbankingnews.comDr. Martens (OTCMKTS:DOCMF) Stock Price Up 4.1%April 29, 2024 | msn.comDominic Fike Is Paying Musical Tribute to Dr. Martens: Shop His Favorite StylesApril 25, 2024 | msn.comDr. Martens Chief Product Officer on How Balancing Brand Heritage with Innovation Can Reignite DemandApril 21, 2024 | msn.comSuitors from world's leading fashion companies try bootmaker Dr Martens on for sizeApril 19, 2024 | msn.comDr. Martens in crisis:Counterfeit Scandal causes drop in valueApril 19, 2024 | msn.comDr. Martens faces historic low as counterfeits flood marketApril 19, 2024 | yahoo.comDominic Fike Partners With Dr. Martens to Celebrate a New Era of the 1460 Icon BootApril 18, 2024 | msn.com5 Unexpected Insights About Dr. Martens CustomersApril 18, 2024 | msn.comHere’s Why We’re Wearing Dr. Martens To Our Next Music FestivalApril 17, 2024 | msn.comHere's Why We're Wearing Dr. Martens To Our Next Music FestivalApril 17, 2024 | seekingalpha.comDr. Martens: Weak FY2025 Outlook Due To Continued Challenges, A Cautious BuyApril 17, 2024 | msn.comDr Martens CEO Kenny Wilson to step downApril 16, 2024 | investopedia.comDr. Martens Stock Plummets on Downbeat US OutlookApril 16, 2024 | msn.comDr Martens shares plunge as tough outlook sets challenge for new CEOApril 16, 2024 | wsj.comDr. Martens Shares Plunge on Profit Warning, CEO ExitApril 16, 2024 | finance.yahoo.comDr. Martens stock plunges on 2025 warning, CEO departureApril 16, 2024 | cnbc.comDr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlookApril 14, 2024 | msn.comDr Marten sues Temu over use of trademark on Google searchApril 6, 2024 | yahoo.comThese TikTok-Famous Dr. Martens Mary Jane Shoes Easily Add Some Cool-Girl Edge to Your Feminine Spring Style — And They’re 40% Off TodayApril 3, 2024 | msn.comInvestors urge Dr. Martens to explore potential saleApril 3, 2024 | msn.comDr Martens should carry out major strategic review, investor claimsApril 3, 2024 | msn.comLondon stocks open lower following global downturn; Dr. Martens shinesSee More Headlines Receive DOCMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolOTCMKTS:DOCMF CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44-12-1415-7047FaxN/AEmployees2,591Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 58)CEO & Director Comp: $961.29kMr. Jon William Mortimore (Age 57)CFO & Director Comp: $625.52kMr. Onyeije Ogueri Nwokorie (Age 54)Chief Brand Officer Comp: $83.32kMr. Geert Peeters (Age 58)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 49)Chief People & Sustainability Officer and Company Secretary Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPresident of APACMr. Adam M. MeekChief Product OfficerMore ExecutivesKey CompetitorsadidasOTCMKTS:ADDDFAmerican RebelNASDAQ:AREBWASICSOTCMKTS:ASCCFGeoxOTCMKTS:GXSBFPumaOTCMKTS:PUMSYView All Competitors DOCMF Stock Analysis - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCMF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCMF, but not buy additional shares or sell existing shares. View DOCMF analyst ratings or view top-rated stocks. How have DOCMF shares performed in 2024? Dr. Martens' stock was trading at $1.1460 on January 1st, 2024. Since then, DOCMF shares have decreased by 5.8% and is now trading at $1.08. View the best growth stocks for 2024 here. Are investors shorting Dr. Martens? Dr. Martens saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 407,100 shares, a decline of 56.3% from the April 15th total of 931,400 shares. Based on an average trading volume of 129,100 shares, the days-to-cover ratio is presently 3.2 days. View Dr. Martens' Short Interest. How do I buy shares of Dr. Martens? Shares of DOCMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DOCMF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.